# VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption

> **NCT02471326** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 10 (actual)

## Conditions studied

- HIV

## Interventions

- **BIOLOGICAL:** VRC-HIVMAB060-00-AB (VRC01)

## Key facts

- **NCT ID:** NCT02471326
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-07-13
- **Primary completion:** 2017-04-07
- **Final completion:** 2017-04-07
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2017-10-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02471326

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02471326, "VRC-HIVMAB060-00-AB (VRC01) in People With Chronic HIV Infection Undergoing Analytical Treatment Interruption". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02471326. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*